Filing Details

Accession Number:
0001104659-21-022113
Form Type:
13G Filing
Publication Date:
2021-02-11 19:00:00
Filed By:
Israel Healthcare Ventures 2 L.p.
Company:
Inmode Ltd. (NASDAQ:INMD)
Filing Date:
2021-02-12
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Israel Healthcare Ventures 0 249,610 0 249,610 249,610 Less than 1%
IHCV 0 249,610 0 249,610 249,610 Less than 1%
Fort Limited 0 7 0 249,610 249,610 Less than 1%
Elton Limited 0 249,610 0 249,610 249,610 Less than 1%
Fort Management Services Limited 0 249,610 0 249,610 249,610 Less than 1%
Jos Ensink 0 249,610 0 249,610 249,610 Less than 1%
Filing
 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C.  20549

 

SCHEDULE 13G/A 

(Amendment No. 1)*

 

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)

 

InMode Ltd.
(Name of Issuer)

 

Ordinary shares, par value NIS 0.01 per share
(Title of Class of Securities)

 

M5425M 103
(CUSIP Number)

 

December 31, 2020
(Date of Event Which Requires Filing of This Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  ¨ Rule 13d-1(b)

 

  ¨ Rule 13d-1(c)

 

  x Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

CUSIP NO. M5425M 103 13G/A Page 2 of  11 Pages

 

1 NAMES OF REPORTING PERSONS
Israel Healthcare Ventures 2 L.P.
2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)  ¨
(b)  x
3 SEC USE ONLY
 
 
4  CITIZENSHIP OR PLACE OF ORGANIZATION
Island of Guernsey
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
5 SOLE VOTING POWER
0
6 SHARED VOTING POWER
249,610
   
7 SOLE DISPOSITIVE POWER
0
   
8 SHARED DISPOSITIVE POWER
249,610
9  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
249,610
 
10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
¨
 
11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1%**
 
12 TYPE OF REPORTING PERSON*
PN

 

*See Item 4.

 

**Based on 32,799,082 ordinary shares, par value NIS 0.01 per share (the “Ordinary Shares”) of the issuer outstanding as of December 31, 2019, based on information set forth in the Form 20-F filed by the issuer on February 18, 2020.

 

 

 

CUSIP NO. M5425M 103 13G/A Page 3 of  11 Pages

 

1 NAMES OF REPORTING PERSONS
IHCV2 General Partner Limited
2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)  ¨
(b)  x
3 SEC USE ONLY
 
 
4  CITIZENSHIP OR PLACE OF ORGANIZATION
Island of Guernsey
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
5 SOLE VOTING POWER
0
6 SHARED VOTING POWER
249,610
   
7 SOLE DISPOSITIVE POWER
0
   
8 SHARED DISPOSITIVE POWER
249,610
9  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
249,610
 
10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
¨
 
11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1%**
 
12 TYPE OF REPORTING PERSON*
PN

 

*See Item 4.

 

** Based on 32,799,082 ordinary shares, par value NIS 0.01 per share (the “Ordinary Shares”) of the issuer outstanding as of December 31, 2019, based on information set forth in the Form 20-F filed by the issuer on February 18, 2020.

 

 

 

 

CUSIP NO. M5425M 103 13G/A Page 4 of  11 Pages

 

1 NAMES OF REPORTING PERSONS
Fort Limited
2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)  ¨
(b)  x
3 SEC USE ONLY
 
 
4  CITIZENSHIP OR PLACE OF ORGANIZATION
Island of Guernsey
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
5 SOLE VOTING POWER
0
6 SHARED VOTING POWER
 
   
7 SOLE DISPOSITIVE POWER
0
   
8 SHARED DISPOSITIVE POWER
249,610
9  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
249,610
 
10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
¨
 
11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1%**
 
12 TYPE OF REPORTING PERSON*
PN

 

*See Item 4.

 

** Based on 32,799,082 ordinary shares, par value NIS 0.01 per share (the “Ordinary Shares”) of the issuer outstanding as of December 31, 2019, based on information set forth in the Form 20-F filed by the issuer on February 18, 2020.

 

 

 

 

CUSIP NO. M5425M 103 13G/A Page 5 of  11 Pages

 

1 NAMES OF REPORTING PERSONS
Elton Limited
2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)  ¨
(b)  x
3 SEC USE ONLY
 
 
4  CITIZENSHIP OR PLACE OF ORGANIZATION
Island of Guernsey
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
5 SOLE VOTING POWER
0
6 SHARED VOTING POWER
249,610
   
7 SOLE DISPOSITIVE POWER
0
   
8 SHARED DISPOSITIVE POWER
249,610
9  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
249,610
 
10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
¨
 
11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1%**
 
12 TYPE OF REPORTING PERSON*
PN

 

*See Item 4.

 

** Based on 32,799,082 ordinary shares, par value NIS 0.01 per share (the “Ordinary Shares”) of the issuer outstanding as of December 31, 2019, based on information set forth in the Form 20-F filed by the issuer on February 18, 2020.

 

 

 

 

CUSIP NO. M5425M 103 13G/A Page 6 of  11 Pages

 

1 NAMES OF REPORTING PERSONS
Fort Management Services Limited
2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)  ¨
(b)  x
3 SEC USE ONLY
 
 
4  CITIZENSHIP OR PLACE OF ORGANIZATION
Island of Guernsey
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
5 SOLE VOTING POWER
0
6 SHARED VOTING POWER
249,610
   
7 SOLE DISPOSITIVE POWER
0
   
8 SHARED DISPOSITIVE POWER
249,610
9  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
249,610
 
10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
¨
 
11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1%**
 
12 TYPE OF REPORTING PERSON*
PN

 

*See Item 4.

 

** Based on 32,799,082 ordinary shares, par value NIS 0.01 per share (the “Ordinary Shares”) of the issuer outstanding as of December 31, 2019, based on information set forth in the Form 20-F filed by the issuer on February 18, 2020.

 

 

 

 

CUSIP NO. M5425M 103 13G/A Page 7 of  11 Pages

 

1 NAMES OF REPORTING PERSONS
Jos Ensink
2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)  ¨
(b)  x
3 SEC USE ONLY
 
 
4  CITIZENSHIP OR PLACE OF ORGANIZATION
Island of Guernsey
 

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
5 SOLE VOTING POWER
0
6 SHARED VOTING POWER
249,610
   
7 SOLE DISPOSITIVE POWER
0
   
8 SHARED DISPOSITIVE POWER
249,610

 

9  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
249,610
 
10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
¨
 
11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1% **
 
12 TYPE OF REPORTING PERSON*
PN

 

*See Item 4.

 

** Based on 32,799,082 ordinary shares, par value NIS 0.01 per share (the “Ordinary Shares”) of the issuer outstanding as of December 31, 2019, based on information set forth in the Form 20-F filed by the issuer on February 18, 2020.

 

 

 

  

Item 1

 

(a) Name of Issuer:

 

InMode Ltd.

 

(b) Address of Issuer’s Principal Executive Offices:
 

Tavor Building, Sha’ar Yokneam

P.O. Box 533

Yokneam 2069200, Israel

 

Item 2

 

(a) - (c) This Schedule 13G is being filed jointly by Israel HealthCare Ventures 2 L.P., a limited partnership registered under the laws of the Island of Guernsey (“IHCV 2”), IHCV2 General Partner Limited, a company incorporated under the laws of the Island of Guernsey (“IHCV2 GP”), Fort Limited, Elton Limited, and Fort Management Services Limited each a company incorporated under the laws of the Island of Guernsey, and Mr. Jos Ensink, each of whom is sometimes referred to herein as a “Reporting Person” and collectively as the “Reporting Persons”.

 

The principal business address of each Reporting Person is Bordage House, Le Bordage, St Peter Port, Guernsey, GY 11BU.

 

(d) Title of Class of Securities: Ordinary Shares
     
(e) CUSIP Number: M5425M 103

 

Item 3 Not applicable.

 

Item 4 Ownership.

 

See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Persons, which are incorporated herein.

 

IHCV 2 beneficially owns 249,610 Ordinary Shares.

 

IHCV2 GP is the general partner of IHCV 2. IHCV2 GP is controlled by its directors Fort Limited and Elton Limited. The controlling shareholder of Fort Limited and Elton Limited is Fort Management Services Limited. The controlling shareholder of Fort Management Services Limited is Mr. Jos Ensink. In such capacities, each of the foregoing Reporting Persons shares voting and dispositive power over, and may be deemed to beneficially own, 249,610 Ordinary Shares, but disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.

 

Item 5 Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof, the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following: 

 

Item 6 Ownership of More Than Five Percent on Behalf of Another Person.

 

Not applicable.

 

Page 8 of 11 Pages

 

 

Item 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.

 

Not applicable.

 

Item 8 Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9 Notice of Dissolution of Group.

 

Not applicable.

 

Item 10 Certification .

 

Not applicable.

 

Page 9 of 11 Pages 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 12, 2021

 

  ISRAEL HEALTHCARE VENTURES 2 L.P.
  IHCV2 GENERAL PARTNER LIMITED
  FORT LIMITED
  ELTON LIMITED
  FORT MANAGEMENT SERVICES LIMITED
JOS ENSINK
  BY: ISRAEL HEALTHCARE VENTURES 2 L.P.
  By:   IHCV2 General Partner Limited
     
  By: /s/ P.M Whitford
  Name: P.M. Whitford
  Title: Director
   
  For itself and on behalf of IHCV2 General Partner Limited, Fort Limited, Elton Limited Fort Management Services Limited and Jos. Ensink, pursuant to an agreement annexed as Exhibit 1 hereto.

 

Page 10 of 11 Pages 

 

 

Exhibit(s) :

 

1 - Joint Filing Agreement

 

Page 11 of 11 Pages